Pacific Biosciences Market Risk Adjusted Performance
| PACB Stock | | | USD 1.41 -0.24 -14.55% |
Market Risk-Adjusted Performance (MRAP) measures return relative to systematic risk (beta) rather than total risk (standard deviation). This isolates the return earned per unit of market exposure, filtering out idiosyncratic volatility that can be diversified away. Below is Pacific Biosciences's current Market Risk Adjusted Performance with peer comparisons and related risk metrics.
Current Market Risk Adjusted Performance Value
Pacific Biosciences's Market Risk Adjusted Performance of
-0.13 reflects slightly negative risk-adjusted return. Pacific Biosciences's return has marginally failed to compensate for the volatility experienced.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.13 | |
| ER[a] | = | Expected return on investing in Pacific Biosciences |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Among sector peers, Pacific Biosciences's Market Risk Adjusted Performance of -0.134 is below the 0.2 group average. The range runs from -0.3635 (Fulgent Genetics) to 0.8927 (DarioHealth Corp). Pacific Biosciences's risk-adjusted return trails the peer average, indicating less efficient compensation for the risk incurred.
Market Risk Adjusted Performance Relative To Other Indicators
The chart below plots Market Risk Adjusted Performance against Maximum Drawdown for Pacific Biosciences and its peers. Each point represents one equity — position along the horizontal axis shows Market Risk Adjusted Performance while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Compare Pacific Biosciences to PeersMethodology, Assumptions & Data Sources
The current Market Risk Adjusted Performance for Pacific Biosciences is -0.13. Pacific Biosciences' Market Risk Adjusted Performance is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. Inputs are drawn from end-of-day closing prices reported by supported exchanges, adjusted for splits and dividends where applicable. Pacific Biosciences operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.
Other Technical Indicators